Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02634801
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 162
Not applicableLooking for participantsNCT06696417
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
First Hospital of China Medical University 1,516
Testing effectiveness (Phase 2)WithdrawnNCT00788424
What this trial is testing

Topical Application of AS101 for the Treatment of Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
BioMAS Ltd
Post-approval studies (Phase 4)Ended earlyNCT00972543
What this trial is testing

Raptiva in Palm and Sole Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 6
Post-approval studies (Phase 4)Ended earlyNCT00739882
What this trial is testing

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 76
Early research (Phase 1)Ended earlyNCT03310320
What this trial is testing

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Vulgaris
AstraZeneca 9
Testing effectiveness (Phase 2)Study completedNCT05531682
What this trial is testing

Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Huabo Biopharm Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Testing effectiveness (Phase 2)Study completedNCT04572997
What this trial is testing

Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)

Who this might be right for
Palmoplantar Pustulosis
Kristian Reich 21
Post-approval studies (Phase 4)UnknownNCT05064748
What this trial is testing

Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults

Who this might be right for
Psoriasis
Peking University People's Hospital 2,000
Early research (Phase 1)Study completedNCT05965089
What this trial is testing

A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.

Who this might be right for
Healthy VolunteersMild to Moderate Psoriasis
Arxx Therapeutics 58
Testing effectiveness (Phase 2)Study completedNCT01936337
What this trial is testing

Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients

Who this might be right for
Psoriasis Vulgaris
Delenex Therapeutics AG 59
Large-scale testing (Phase 3)Study completedNCT00674063
What this trial is testing

Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 78
Not applicableLooking for participantsNCT06792487
What this trial is testing

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

Who this might be right for
Psoriasis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Large-scale testing (Phase 3)Study completedNCT03370133
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 567
Large-scale testing (Phase 3)Study completedNCT02346240
What this trial is testing

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 559
Large-scale testing (Phase 3)Study completedNCT00574249
What this trial is testing

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

Who this might be right for
Chronic Plaque Psoriasis
Abbott 730
Not applicableNot Yet RecruitingNCT06811558
What this trial is testing

Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

Who this might be right for
Over 70-year-old Patients with Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT05223868
What this trial is testing

JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 255
Early research (Phase 1)Study completedNCT01094093
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AstraZeneca 73
Next Page